Veena Rajashekhar
Allergy & Immunology · Round Rock, TXNPI 1356342612
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 29.7% of the total. Reporting peaked in 2019 at $2,233 and has fallen 71.8% since, to $630 in 2025.
Across 202 payments — averaging $34.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$857
- Sanofi$809
- Regeneron Healthcare Solutions, Inc.$530
- Genentech USA, Inc.$419
- Biohaven Pharmaceuticals, Inc.$253
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,92299%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $2,069 |
| GSK | 37 | $857 |
| Sanofi | 24 | $809 |
| Regeneron Healthcare Solutions, Inc. | 15 | $530 |
| Genentech USA, Inc. | 9 | $419 |
| Biohaven Pharmaceuticals, Inc. | 7 | $253 |
| Blueprint Medicines Corporation | 2 | $248 |
| Alk-abello, Inc | 8 | $219 |
| Amgen | 2 | $195 |
| Pfizer | 6 | $186 |
| Teva Pharmaceuticals USA, Inc. | 3 | $156 |
| Galderma Laboratories, L.p. | 1 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $136 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Shire North American Group Inc | 3 | $106 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Kaleo, Inc. | 3 | $67 |
| Philips North America LLC | 4 | $62 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $59 |
| Greer Laboratories, Inc. | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Novartis | 2 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,960 in reported general payments places this provider in the 55th percentile of 336 allergy & immunology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 13 | $176 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Round Rock
- Joseph DiazSan Antonio$1.1M
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lukena KarkhanisSan Antonio$377K
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
- Lara GrossDallas$171K
- Bobby LanierBenbrook$149K
- Juan ZambranoHouston$146K
- Serge de GolovineBellaire$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.